Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter November 2013

Gene Therapy Net Banner
News: Gene therapy company launched
Fidelity Biosciences, a venture capital firm that is a subsidiary of Fidelity Investments, and REGENX Biosciences, announced the formation of Dimension Therapeutics, a Cambridge gene therapy company focused on developing treatments for rare diseases such as hemophilia. Dimension has completed an undisclosed Series A financing that was led by Fidelity Biosciences.

Conference: Gene-based Therapeutics for Neurological Disorders: From Basic Science to Clinical Applications
There are still some oral slots available for our forthcoming ‘’Gene-based Therapeutics for Neurological Disorders: From Basic Science to Clinical Applications” conference, 8-11 February 2014 at the Fiesta Americana Condesa Resort, Cancun, Mexico.

This is a great opportunity to assemble a rich programme of international speakers to address the latest advances in gene therapy, from basic research of vector design, modelling and pre-clinical testing to clinical applications in CNS disorders such as Parkinson’s, Alzheimer’s, Huntington’s, motor neuron diseases and eye diseases.

The conference will bring together basic and clinical scientists to discuss recent discoveries in genetics and mechanisms of disease (e.g. the role of RNA metabolism and processing in neurological diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), spinal muscular atrophy (SMA), and repeat expansion disorders) and how these discoveries could help develop novel gene based therapeutics for neurodegenerative diseases. Further topics such as challenges in vector manufacturing and views of regulatory agencies on gene therapy clinical applications will be discussed.

Plenary Speakers include: Professor Richard Jude Samulski (University of North Carolina) Professor Jeffrey H. Kordower (Rush University, Chicago) and Professor Ronald G Crystal (Weill Medical College of Cornell University).

Invited Speakers include: Dr Krystof Bankiewicz (University of California), Dr Howard Federoff (Georgetown University, Dr Maria Kinali (Imperial College, London), Dr Brian Kaspar (Nationwide Children's Hospital, Columbus) and Dr Fraser Wright (Childrens Hospital of Philadelphia).

If you are interested in presenting orally or via a poster, please register for the conference to ensure ample time for abstract consideration. If you are looking to only attend, please register with us as soon as possible to ensure you secure a place. Registration closes on 13 December 2013: Register now

Dates: February 8-11, 2014
Venue: Cancun, Mexico


Conference: XX Annual Meeting of the German Society for Gene Therapy
'Barriers and Progress in Gene and Cell Therapy' is the overriding theme of this meeting to stimulate discussion on those things "which are not yet working well enough" and also on future directions. A better understanding of current barriers and hurdles will contribute to improved therapeutic activity and safety of gene and cell therapeutics see attachment for program).

The meeting will start in the morning of March 20 (Thursday) at 9:00 (9:00 am) with an opening symposium on the state-of-the-art in production of gene and cell therapeutics, presented by several experts with deep insight into this topic. Therefore, we strongly recommend that you plan your travel for an arrival on Wednesday, March 19, evening. For those arriving on Wednesday we will have a special early bird reception in the old City of Ulm on Wednesday at 19:00 (7:00 pm).

Registration is now open:

Dates: March 20–22, 2014
Venue: University Clinic Ulm Oberer Eselsberg, Germany


- 20 – 22 November 2013, 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California
- 27 - 29 January 2014, Phacilitate 10th Annual Cell & Gene Therapy Forum 2014, Washington DC, MD
- 8 -11 February 2014, Gene-based Therapeutics for Neurological Disorders, Cancun, Mexico
- 20 -22 March 2014, 20th Annual Meeting of the German Society for Gene Therapy (DG-GT e.V.), Ulm, Germany
- 28 March 2014, Annual conference of the British Society for Gene Therapy (BSGT), London, UK
- 21 – 24 May 2014, American Society of Gene and Cell Therapy (ASGCT) 17th Annual Meeting, Washington, DC
- 6 – 8 August 2014, The 20th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokio, Japan
- 11 – 13 August 2014, The 2nd International Conference on Genetic Engineering & Genetically Modified Organisms, San Antonio, TX
- 23 – 26 October 2014, XXII Congress of the European Society of Gene and Cell Therapy (ESGCT), The Hague, The Netherlands
- 27 – 29 October 2014, 3rd International Conference and Exhibition on Cell & Gene Therapy, Las Vegas, NV


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net and Chikungunya Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?